MariMed Announces Fourth Quarter and Full Year 2024 Earnings Date
MariMed Inc. (CSE: MRMD, OTCQX: MRMD), a multi-state cannabis operator, has scheduled its fourth quarter and full year 2024 earnings release for March 5, 2025, after market close. The company will host a conference call to discuss the financial results on March 6, 2024, at 8:00 a.m. EST. A webcast will be available through MariMed's Investor Relations website, with a playback option provided afterward.
MariMed Inc. (CSE: MRMD, OTCQX: MRMD), un operatore multi-statale nel settore della cannabis, ha programmato il suo rilascio dei guadagni del quarto trimestre e dell'intero anno 2024 per il 5 marzo 2025, dopo la chiusura del mercato. L'azienda ospiterà una conferenza telefonica per discutere i risultati finanziari il 6 marzo 2024, alle 8:00 EST. Un webcast sarà disponibile attraverso il sito web delle Relazioni con gli Investitori di MariMed, con un'opzione di riproduzione fornita successivamente.
MariMed Inc. (CSE: MRMD, OTCQX: MRMD), un operador de cannabis en múltiples estados, ha programado su informe de ingresos del cuarto trimestre y del año completo 2024 para el 5 de marzo de 2025, después del cierre del mercado. La compañía llevará a cabo una conferencia telefónica para discutir los resultados financieros el 6 de marzo de 2024, a las 8:00 a.m. EST. Habrá un webcast disponible a través del sitio web de Relaciones con Inversores de MariMed, con una opción de reproducción proporcionada posteriormente.
MariMed Inc. (CSE: MRMD, OTCQX: MRMD), 다수 주에서 운영되는 대마초 사업체,는 2024년도 4분기 및 연간 실적 발표를 2025년 3월 5일 시장 마감 후로 예정하였다. 회사는 2024년 3월 6일 동부 표준시 기준 오전 8시에 재무 결과를 논의하기 위한 전화 회의를 개최할 예정이다. MariMed의 투자자 관계 웹사이트를 통해 웨비나가 제공되며, 이후 재생 옵션이 제공된다.
MariMed Inc. (CSE: MRMD, OTCQX: MRMD), un opérateur de cannabis multi-état, a programmé sa publication des résultats financiers du quatrième trimestre et de l'année 2024 pour le 5 mars 2025, après la clôture du marché. L'entreprise tiendra une conférence téléphonique pour discuter des résultats financiers le 6 mars 2024, à 8h00 HNE. Un webinaire sera disponible via le site web des Relations Investisseurs de MariMed, avec une option de rediffusion fournie par la suite.
MariMed Inc. (CSE: MRMD, OTCQX: MRMD), ein multistaatlicher Betreiber von Cannabis, hat die Veröffentlichung seiner Quartals- und Jahresergebnisse 2024 für den 5. März 2025 nach Börsenschluss geplant. Das Unternehmen wird am 6. März 2024 um 8:00 Uhr EST eine Telefonkonferenz abhalten, um die Finanzergebnisse zu besprechen. Ein Webinar wird über die Website der Investor Relations von MariMed verfügbar sein, mit einer nachträglichen Wiedergabeoption.
- None.
- None.
NORWOOD, Mass., Feb. 11, 2025 (GLOBE NEWSWIRE) -- MariMed Inc. (“MariMed” or the “Company”), (CSE: MRMD), (OTCQX: MRMD), a leading multi-state cannabis operator focused on improving lives every day, announced today it will report fourth quarter and full year 2024 financial results on March 5, 2025 after the markets close. Management will host a conference call on March 6, 2024, at 8:00 a.m. EST to discuss financial results.
A webcast will be available and can be accessed via MariMed’s Investor Relations website at MariMed Q424 Earnings Webcast. A playback of the call will also be made available on MariMed’s Investor Relations website.
About MariMed
MariMed Inc. is a leading multi-state cannabis operator, known for developing and managing state-of-the-art cultivation, production, and retail facilities. Our award-winning portfolio of cannabis brands, including Betty's Eddies™, Bubby’s Baked™, Vibations™, InHouse™, and Nature’s Heritage™, sets us apart as an industry leader. These trusted brands, crafted with quality and innovation, are recognized and loved by consumers across the country. With a commitment to excellence, MariMed continues to drive growth and set new standards in the cannabis industry. For additional information, visit www.marimedinc.com.
Company Contact:
Howard Schacter
Chief Communications Officer
Email: ir@marimedinc.com
Phone: (781) 277-0007
FAQ
When will MariMed (MRMD) release its Q4 2024 earnings?
What time is MariMed's (MRMD) Q4 2024 earnings call?
How can investors access MariMed's (MRMD) Q4 2024 earnings call?
Will there be a replay available for MariMed's (MRMD) Q4 2024 earnings call?
